Reasearch
All posts tagged with “glioblastoma” Clear Tags
-
Cancer, NeurologyIntensive Multimodal Ketogenic Metabolic Therapy in Glioblastoma: A Clinical Trial
Glioblastoma (GBM), isocitrate dehydrogenase (IDH)-wildtype, is the most common and aggressive primary brain tumor in adults, with a median overall survival of approximately 11–14 months...
-
Cancer, Exercise & Sports PerformanceTargeting differential energy substrate metabolism on a therapeutic ketogenic diet: a case report
This case report examines the relationship between exercise intensity and blood ketone levels in a 44-year-old male patient with glioblastoma who followed a therapeutic ketogenic...
-
CancerCritical Review of Ketogenic Diet Throughout the Cancer Continuum for Neuroglioma: Insights from a Medical Nutrition Therapy (MNT) Perspective
The ketogenic diet has gained attention as a potential adjunct therapy for neurogliomas, including glioblastoma and astrocytoma. These aggressive brain tumors have low survival rates,...
-
CancerA phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma
A phase 1, single-arm clinical trial investigated the safety and feasibility of implementing a ketogenic diet (KD) alongside standard-of-care chemoradiation in patients with newly diagnosed glioblastoma (GBM), a highly aggressive brain...
-
CancerTherapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma
Glioblastoma (GBM) is a highly aggressive brain tumor with limited effective treatment options. Despite the known role of glucose and glutamine in fueling GBM growth,...
-
CancerSystematic Review and Clinical Insights: The Role of the Ketogenic Diet in Managing Glioblastoma in Cancer Neuroscience
Glioblastoma (GBM) is the most common and aggressive primary central nervous system tumor, and it has a very poor prognosis. Despite advancements in treatments such...
-
CancerKetogenic metabolic therapy in conjunction with standard treatment for glioblastoma: a case report
Glioblastoma (GBM) is a highly aggressive brain tumor with a median survival rate of 12 to 15 months under standard care, which includes surgery, radiation,...